Immunome (IMNM) Leases (2023 - 2025)
Historic Leases for Immunome (IMNM) over the last 3 years, with Q3 2025 value amounting to $3.1 million.
- Immunome's Leases rose 3086.26% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year increase of 3086.26%. This contributed to the annual value of $4.3 million for FY2024, which is 17352.94% up from last year.
- As of Q3 2025, Immunome's Leases stood at $3.1 million, which was up 3086.26% from $3.3 million recorded in Q2 2025.
- Over the past 5 years, Immunome's Leases peaked at $4.3 million during Q4 2024, and registered a low of $174000.0 during Q2 2023.
- Its 3-year average for Leases is $2.3 million, with a median of $2.4 million in 2024.
- Within the past 5 years, the most significant YoY rise in Immunome's Leases was 135000.0% (2024), while the steepest drop was 677.75% (2024).
- Quarter analysis of 3 years shows Immunome's Leases stood at $1.6 million in 2023, then surged by 173.53% to $4.3 million in 2024, then dropped by 26.95% to $3.1 million in 2025.
- Its last three reported values are $3.1 million in Q3 2025, $3.3 million for Q2 2025, and $4.2 million during Q1 2025.